references

Portfolio R&D - Over 160 R&D partners worlwide (6/20)

Portfolio R&D - (1/20)
Portfolio R&D - (2/20)
Portfolio R&D - (3/20)
Portfolio R&D - (4/20)
Portfolio R&D - (5/20)
Portfolio R&D - Over 160 R&D partners worlwide (6/20)
Portfolio R&D - (7/20)
Portfolio R&D - (8/20)
Portfolio R&D - (9/20)
Portfolio R&D - (10/20)
Portfolio R&D - (11/20)
Portfolio R&D - (12/20)
Portfolio R&D - (13/20)
Portfolio R&D - 7 new treatments delivered (14/20)
Portfolio R&D - (15/20)
Portfolio R&D - (16/20)
Portfolio R&D - 3 clinical research platfomrs established (17/20)
Portfolio R&D - (18/20)
Portfolio R&D - (19/20)
Portfolio R&D - (20/20)

Scientific Network Over 160 R&D PARTNERS worldwide Project Partners Research Translation Development Implementation Platform Member Countries Founding Partners DNDi Worldwide ners h on ment ntation Member Countries g Partners rldwide Founding Partners • Médecins Sans Frontières (MSF) (Doctors Without Borders) • Oswaldo Cruz Foundation, Brazil • Indian Council for Medical Research, India • Kenya Medical Research Institute, Kenya • Ministry of Health, Malaysia • Institut Pasteur, France • The Special Programme for Research and Training in Tropical Diseases (WHO-TDR) DNDi Worldwide • DNDi Headquarters (Geneva) • DNDi Latin America (Rio de Janeiro) • DNDi North America (New York) • DNDi Africa (Nairobi) • DNDi India (Delhi) • DNDi South East Asia (Kuala Lumpur) • DNDi Japan (Tokyo) • DNDi in DRC (Kinshasa) Clinical Research Platforms LEISHMANIASIS EAST AFRICA PLATFORM (LEAP) CHAGAS CLINICAL RESEARCH PLATFORM (CCRP) HUMAN AFRICAN TRYPANOSOMIASIS (HAT) PLATFORM 6 • R&D Portfolio